- Home
- OCC vs IMMX Comparison
OCC vs IMMX Comparison
Compare OCC & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCC
- IMMX
- Stock Information
- Founded
- OCC 1983
- IMMX 2014
- Country
- OCC United States
- IMMX United States
- Employees
- OCC N/A
- IMMX N/A
- Industry
- OCC Telecommunications Equipment
- IMMX Medicinal Chemicals and Botanical Products
- Sector
- OCC Industrials
- IMMX Health Care
- Exchange
- OCC Nasdaq
- IMMX Nasdaq
- Market Cap
- OCC 42.9M
- IMMX 50.1M
- IPO Year
- OCC 1996
- IMMX 2021
- Fundamental
- Price
- OCC $2.79
- IMMX $1.75
- Analyst Decision
- OCC
- IMMX Strong Buy
- Analyst Count
- OCC 0
- IMMX 1
- Target Price
- OCC N/A
- IMMX $7.00
- AVG Volume (30 Days)
- OCC 26.6K
- IMMX 47.5K
- Earning Date
- OCC 03-10-2025
- IMMX 05-08-2025
- Dividend Yield
- OCC N/A
- IMMX N/A
- EPS Growth
- OCC N/A
- IMMX N/A
- EPS
- OCC N/A
- IMMX N/A
- Revenue
- OCC $67,561,951.00
- IMMX N/A
- Revenue This Year
- OCC N/A
- IMMX N/A
- Revenue Next Year
- OCC N/A
- IMMX N/A
- P/E Ratio
- OCC N/A
- IMMX N/A
- Revenue Growth
- OCC N/A
- IMMX N/A
- 52 Week Low
- OCC $2.02
- IMMX $1.26
- 52 Week High
- OCC $7.00
- IMMX $3.13
- Technical
- Relative Strength Index (RSI)
- OCC 31.69
- IMMX 41.38
- Support Level
- OCC $3.19
- IMMX $1.64
- Resistance Level
- OCC $3.67
- IMMX $1.90
- Average True Range (ATR)
- OCC 0.26
- IMMX 0.14
- MACD
- OCC -0.02
- IMMX 0.00
- Stochastic Oscillator
- OCC 20.00
- IMMX 10.44
About OCC Optical Cable Corporation
Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, renewable energy and broadcast applications, and for the wireless carrier market.
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.